Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | 0.00% | +5.88% | -48.57% |
May. 22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
10.4M | - | - | - | - | - | |
123B | ||||||
111B | ||||||
23.63B | - | |||||
22.58B | - | |||||
17.61B |